CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia

Clinical Cancer Research

Volumn 11, Issue 2 I, 2005, Pages 505-511

  Kosugi, Nobuharu ^a   Ebihara, Yasuhiro ^a   Nakahata, Tatsutoshi ^a,c   Saisho, Hiromitsu ^b   Asano, Shigetaka ^a   Tojo, Arinobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CD34 ANTIGEN; CD7 ANTIGEN; IMATINIB;

ARTICLE; CELL SELECTION; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL DETECTION; STEM CELL;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTIGENS, CD7; BONE MARROW; CHROMOSOME ABERRATIONS; CLONE CELLS; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; FEMALE; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; STEM CELLS; TISSUE DONORS;

EID: 12244285929     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sawyers CL. Chronic myeloid leukemia. N Engl J Med 1999;340:1330-40.
2. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210BCR-ABL gene of the Philadelphia chromosome. Science 1990;247:824-30.
3. Warmuth M, Danhauser-Riedl S, Hallek M. Molecular pathogenesis of chronic myeloid leukemia: implication for new therapeutic strategies. Ann Hematol 1999;78:49-64.
4. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-30.
5. LeBien TW, Hozier J, Minowada J, Kersey JW. Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes. N Engl J Med 1979;301:144-7.
6. Martin PJ, Najfeld V, Hausen JA, Penfold GK, Jacobsen RJ, Fialkow PJ. Involvement of the B-lymphoid system in chronic myelogenous leukemia. Nature 1980;287:49-50.
7. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A 1989;86:6783-7.
8. Marshal R, Shtalrid M, Talpatz M, et al. Rearrangement and expression of p53 in chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990;75:180-9.
9. Mitani K, Ogawa S, Tanaka T, et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 1994;13:504-10.
10. Majlis A, Smith TL, Talpaz M, O'Brien S, Rios MB, Kantarjian H. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. J Clin Oncol 1996;14:196-203.
11. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-a produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann Intem Med 1991;114:532-8.
12. Kantarjian H, Sawyers C, Hochhous A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002;346:645-52.
13. Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. J Clin Invest 1994;94:1383-9.
14. Coulombel L, Lalousek DK, Eaves CJ, Gupta CM, Eaves AC. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 1983;308:1493-8.
15. Verfaillie CM, Miller WJ, Boylan K, McGlave PB. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992;79:1003-10.
16. lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood 1995;86:737-43.
17. + cells isolated from the mobilized peripheral blood of α-interferon-resistant or -intolerant patients with chronic myeloid leukemia. Blood 1996;87:4348-57.
18. Kosugi N, Tojo A, Shinzaki H, Nagamura-Inoue T, Asano S. The preferential expression of CD34 and CD7 in myeloid blast crisis in chronic myeloid leukemia. Blood 2000;95:2188-9.
19. + cells from chronic myeloid leukemia in chronic phase. Am J Hematol 1999;61:178-86.
20. + cells in CML patients, of prognostic significance? Eur J Haematol 2003;71:266-75.
21. Sempowski GD, Lee DM, Kaufman RE, Haynes B. Structure and function of the CD7 molecule. Crit Rev Immunol 1999;19:331-48.
22. Talpaz M, Kantarjian H, McCredie KB, Keating MJ, Trujillo J, Gutterman J. Clinical investigation of human α interferon in chronic myelogenous leukemia. Blood 1987;69:1280-8.
23. + hematopoietic stem and progenitor cells. Cytometry 1998;34:128-42.
24. Miyoshi H, Ohira M, Shimizu K, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 1995;23:2762-9.
25. Barcena A, Muench MO, Galy AHM, Roncarolo MG, Phillips JH, Spits H. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stage of T- and myeloid-cell development. Blood 1993;82:3401-14.
26. Grumayer ER, Griesinger F, Hummell DS, Brunning RD, Kersey JH. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7. Blood 1991;77:64-8.
27. Gore SD, Kasten MB, Civin CI. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 1991;77: 1681-90.
28. Chabannon C, Wood P, Torok-Storb B. Expression of CD7 on normal human myeloid progenitors. J Immunol 1992;149:2110-3.
29. + bone marrow cells. J Exp Med 1993;177:1531-9.
30. Lo Coco F, De Rosssi G, Pasqualetti D, et al. CD7 positive acute myeloid leukemia: A subtype associated with cell immaturity. Br J Haematol 1989;73:480-5.
31. Dewald GW, Schad CR, Christensen ER, et al. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 1993;71: 7-14.
32. Takahashi N, Miura I, Saitoh K, Miura AB. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 1998;92:4758-63.
33. Jiang X, Lopez A, Hplyoake T, Eaves A, Eaves C. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia. Proc Natl Acad Sci U S A 1999;96:12804-9.
34. Jamieson CHM, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004;351:657-67.
35. Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC. Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem 2000;275:3431-7.
36. Lee DM, Patel DD, Pendergast AM, Haynes BF. Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif. Int Immunol 1996;8:1195-203.
37. Skorski T, Bellacosa A, Nieborowska-Skorska M, et al. transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J 1997;16:6151-61.
38. Hou Z, Leta E, Jung LK. Cross-linking CD7 on myeloblasts results in granulocyte-macrophage colony-stimulating factor production. Blood 1996;88:124-9.
39. Despres D, Goldschmitt J, Aulitzky WE, Huber C, Peschel C. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL3-stimulated normal and CML myeloid progenitors. Exp Hematol 1995;23:1431-8.